Which new antiepileptic drug for which patient? - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

Which new antiepileptic drug for which patient?

Description:

AEDs are mainstay treatment. Non-pharmacological options feasible in only few selected cases ... AEDs are mainstay treatment. Treatment empirical rather than rational! ... – PowerPoint PPT presentation

Number of Views:253
Avg rating:3.0/5.0
Slides: 38
Provided by: natio1
Category:

less

Transcript and Presenter's Notes

Title: Which new antiepileptic drug for which patient?


1
The Medical and Surgical Treatment of Epilepsy
Professor Ley Sander Department of Clinical and
Experimental Epilepsy UCL Institute of
Neurology National Hospital for Neurology
Neurosurgery Queen Square, London WC1N 3BG
2
The Treatment of Epilepsy
  • The incidence and prevalence
  • Aetiologies and risk factors
  • Aims of treatment
  • Clinical settings
  • Principles of treatment
  • Medical treatment
  • Surgical treatment
  • Guidelines
  • Conclusions

3
Incidence and Prevalence
  • Incidence of new cases of epilepsy
  • 50/100,000/year
  • Incidence of single seizures
  • 20 - 30/100,000/year
  • Prevalence of active epilepsy
  • 5 - 10/1,000 (50 because on AEDs)
  • Severe epilepsy 1 - 2/1,000
  • Cumulative Incidence (lifetime prevalence)
  • 2 - 5

4
Incidence and Prevalence in the UK
  • 30 000 new cases a year
  • 300 000 - 400 000 cases
  • 72 000 - 80 000 cases of severe epilepsy

5
Incidence and Prevalence in the UK
  • GP
  • 1 - 2 new cases of epilepsy/year
  • 10 - 12 cases of active epilepsy
  • Neurologist
  • 150 cases of epilepsy/single seizures/year
  • 1,200 cases of active epilepsy

6
Epilepsy Aetiologies and Risk Factors
  • Risk factors varies with age and geographic
    location
  • Congenital, developmental and genetic conditions
    in childhood, adolescence and young adults
  • Head trauma, infection and tumours at any age
    although tumours more likely over age 40
  • Cerebrovascular disease common in elderly
  • Endemic infections are associated with epilepsy
    in certain areas
  • malaria, neurocysticercosis, paragonomiasis,
  • no adequate large scale study of attributable
    risk yet

7
Antiepileptic Treatment
  • AEDs are mainstay treatment
  • Non-pharmacological options feasible in only few
    selected cases
  • Surgery
  • Curative
  • Palliative
  • Ketogenic diet (children)
  • Behaviour modification
  • Avoidance therapy in cases with clear
    precipitants

8
Aims of Antiepileptic Treatment
  • Complete seizure freedom
  • 50 seizure reduction of little benefit
  • No adverse effects
  • long term treatment - long term effects ?
  • cognitive effects debilitating
  • teratogenicity
  • Non-obtrusive treatment
  • once or twice daily
  • No PK or PD interactions
  • Maintenance of a normal lifestyle
  • Reduction in morbidity and mortality

9
AED Treatment Clinical Settings
  • Prophylactic Treatment
  • Newly Diagnosed Epilepsy
  • Single seizure
  • Recurrent seizures
  • Chronic Epilepsy

10
Prophylactic use of AEDs
  • Often advocated after
  • Head injury
  • Craniotomy
  • There are considerable compliance problems
  • There is no evidence of a protective effect of
    this policy
  • No place for this!
  • Better wait for the event to happen

11
Is it Epilepsy ?
  • Newly diagnosed or suspected cases at Primary
    Care level
  • gt 50 not epilepsy
  • commonest differential diagnosis syncope
  • Chronic cases
  • 15 - 20 not epilepsy
  • mostly psychological in nature
  • Careful diagnostic assessment a must in all cases

12
The Single Seizure
  • A controversial area!
  • Single unprovoked attack usually not treated
    practice to defer treatment until 2 or more
    seizures, although patients at high risk may be
    treated after a first attack
  • Incidence of epilepsy much greater than of single
    seizures
  • Community-based studies show that overall risk of
    a second seizure greater than previously accepted
  • selection bias
  • Patients
  • Seizure type
  • time to entry bias

13
The Single Seizure
  • AED treatment following a single seizure reduce
    risk of recurrence in the short term although
    long term prognosis not changed
  • This may eventually lead to changes in the way
    single seizures are managed
  • treatment after first seizure
  • - for six months, for a year?
  • tailored treatment and not symptomatic
  • Meanwhile, involve patient and or guardians in
    the decision

14
Recurrent Seizures
  • Treatment recommended after two or more seizures
  • Exceptions
  • - Long interval between seizures
  • - Clear identifiable precipitant factor
  • - Patient against treatment
  • - Unlikely compliance

15
Precipitating Factors
  • Fever
  • Drugs
  • Alcohol
  • Photo-Sensitivity
  • Sleep Deprivation
  • Reflex Mechanisms
  • Acute Metabolic Stress
  • Emotional Stress/Major Life Events

16
Starting an AED
  • Starting AED treatment is a major event and
    should not be undertaken without careful
    evaluation of all relevant factors
  • Therapy is a long term prospect
  • All implications must be fully explained to the
    individual and or guardian
  • Paramount that the patient or guardians are kept
    informed about the treatment process and the
    rationale behind it

17
Starting Treatment
  • Treatment should always be started with a single
    drug at a small dose
  • All common side-effects must be discussed
  • teratogenicity and contraception if applicable
  • Importance of compliance should be stressed
  • Careful titration is a must
  • - start low, go slow

18
Choice of AEDs treatment
  • Choice of AED influenced by
  • Type of seizure and or epileptic syndrome
  • Individual circumstances of patient
  • Side effect profile of drug
  • Personal preferences
  • No clear cut evidence based medicine is
    available!
  • Clinical practice is based more on dogmatic
    teaching than on scientific knowledge
  • Empirical rather than rational

19
Principles of AED treatment
  • Diagnosis clearly established
  • Appropriate first line drug for syndrome and
    patient
  • One drug at a time as a rule
  • If first drug ineffective add another first line
    drug and then withdraw first drug
  • Combination therapy only when single drug
    ineffective

20
What Is Chronic Epilepsy ?
  • Active 2 years after onset
  • Failed 2 first line AEDs
  • Great number of seizure in early history

21
Chronic Epilepsy 1
  • Review history of epilepsy
  • - Obtain and review old notes if possible
  • - Interview patient and witness
  • - Classify seizures
  • Review diagnosis
  • - Non-epileptic events
  • - Identifiable aetiology
  • - High resolution MRI scanning
  • Question Compliance
  • Check serum AED levels
  • Review past and present AED treatment for
    efficacy and side-effects

22
Chronic Epilepsy 2
  • Select the AED that is most likely to be
    efficacious and with the least side-effects
  • Adjust the dose of the selected drug to the
    optimum
  • Attempt to reduce and taper other AEDs
  • If seizures continue despite a maximally
    tolerated dose of a first-line drug
  • - Check compliance
  • tablet count, serum levels, counselling
  • Commence another first-line AED if there is one
    that has not been used to its optimum

23
Chronic Epilepsy 3
  • If seizures continue try a combination of two
    AEDs
  • If combination unhelpful, AED which appears
    most effective and with fewer side-effects should
    be continued and the other AED replaced
  • If this drug is effective, withdrawal of the
    initial agent should be considered if not, it
    should be replaced by another AED
  • Consider the possibility of surgical treatment
  • Consider using an experimental AED

24
Inappropriate use of AEDs
  • Inappropriate treatment of people who do not have
    epilepsy
  • Inappropriate drug treatment of patients who do
    have epilepsy
  • JME easily treated with some AEDs but poorly
    controlled with others
  • Partial epilepsies often misdiagnosed as
    generalised epilepsy
  • Incorrect dosages or inappropriate use of
    polytherapy
  • Overzealous adherance to therapeutic AED drug
    levels

25
AED drug levels monitoring
  • Measurement of AED levels
  • drug toxicity occurs and needs to be documented
  • suspected non-compliance
  • suspected drug interactions
  • during pregnancy (free levels)
  • during systemic illness
  • phenytoin therapy
  • Not a guide to dosing!

26
Who Should be Evaluated for Surgery
  • Partial seizures simple, complex, sec gen.
  • Stereotyped onset
  • No non-epileptic attacks
  • No contraindication for Neurosurgery
  • Active epilepsy for gt2-3 yr, despite 3 AEDs
  • Inadequate seizure control gt 1-2 c p s /month
  • Acceptance of best risk / benefit ratio

27
Best risk vs benefit ratio of temporal lobe
epilepsy surgery
  • Medical Surgical
  • Chance of seizure control
  • 10 70
  • Risk
  • Morbidity from seizures 1/100 long-lasting
    impairment
  • Psychosocial handicap hemiparesis,
    aphasia
  • 1/100 Annual mortality 1/20 quandrantanopia
    prevents driving

28
Range of Epilepsy Surgery
  • 70 Anterior temporal lobe resection
  • 20 Extra-temporal cortical resection
  • Lesionectomy
  • 10 Palliative Procedures
  • Hemispherectomy
  • Corpus callosotomy
  • Subpial transection
  • Vagal Nerve Stimulation

29
Components of Presurgical Evaluation
  • Convergence of data
  • One epileptogenic dysfunctional area
  • Rest of brain normal
  • Clinical
  • Neuro-Imaging
  • EEG
  • Neuropsychology
  • Neuropsychiatry
  • Psychosocial

30
Psychosocial
  • Realistic expectations?
  • Improvement in life from seizure control?
  • Intelligence, memory will not improve
  • Not more attractive, employable
  • Need to continue AEDs after
  • Social support
  • Family, friends, community, finances

31
Neuro-imaging
  • Fundamental
  • MRI predicts nature and extent of pathology
  • Unusual to resect area with normal imaging
  • Poor results if imaging normal

32
Pathology and Outcome
  • TLE Anterior Temporal Lobe resection
  • Focal pathology 70 seizure free, 25 gt90
    reduced
  • DNT, cavernomagtHSgtAVMgttraumagtMCD
  • 20 seizure free if no focal pathology
  • Extra Temporal Lobe
  • Focal pathology 60 seizure free, 20 gt90
    reduced
  • DNT, cavernoma, gliomagtAVMgttrauma
  • MCD 20-30 seizure free, if focal
  • lt20 seizure free if no focal pathology

33
Treatment Guidelines for Epilepsy
  • NICE www.nice.org.uk National Institute for
    Clinical Excellence (England and Wales)
  • SIGN www.sign.ac.uk Scottish Intercollegiate
    Guidelines Network (Scotland)
  • AAN www.aan.com American Academy of Neurology
    (USA)

34
Primary Care Guidelines for Epilepsy
  • Referral of ALL who experience a suspected
    seizure
  • Seen within 14 days by specialist
  • Risk and safety precautions documented
  • Care Plan in place
  • At least a yearly review
  • Early re-referral if
  • Treatment failure
  • Seizures not controlled
  • Diagnostic uncertainty
  • Considering pregnancy
  • Considering drug withdrawal

35
Managing People With Epilepsy
  • Holistic issues
  • Interest and continuity of care
  • Clear plan
  • Information provision
  • SUDEP
  • Easy access
  • - Practical Issues
  • Cooking, Bathing, Driving, Contraception,
    Conception
  • - Reasonable Expectations
  • Prognosis, Independent Living, Employment

36
AED Treatment Conclusions
  • Correct diagnosis and classification paramount to
    treatment
  • AEDs are mainstay treatment
  • Treatment empirical rather than rational!
  • gt 70 of patients become seizure free
  • Potential complications toxicity
  • Low threshold for s/effects

37
AED Treatment Conclusions
  • Potential for misuse of AEDs not to be dismissed
  • New AEDs may be better tolerated, but more
    effective?
  • Chronic side effect profile of new AEDs not fully
    known
  • Surgical treatment very successful but only
    possible in a few selected cases
  • Consider stopping AED if seizure free for years
  • New treatment still needed!
Write a Comment
User Comments (0)
About PowerShow.com